About Sontra Medical
Developer of ultrasound technology for drug delivery, fluid withdrawal, and monitoring of glucose levels for diabetics. The company develops non-invasive diagnostic and transdermal drug delivery products which utilize low frequency ultrasound to increase skin permeability. The company is performing research and development on the SonoPrep Skin Permeation System. The system is being designed to provide a convenient and painless method of enhancing transport of molecules through human skin. After a brief application of ultrasound to skin, the skin would be permeable for an extended period of time (12 to 15 hours).